Sun Pharmaceutical Industries

Activities: Research & Development Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Drug Delivery

Sun Pharma enters definitive financial agreement with Concert

Concert stockholders will also receive a tradable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share of common stock in cash
Ingredients

Sun Pharma questions pandemic effects on business

Director has said performance reflects the impact of the global COVID-19 pandemic but vertical integration has benefitted supply chain for formulations
Finance

Sun Pharma licenses seven generics to Chinese company

China Medical System Holdings subsidiary will develop and commercialise the Indian company's seven generic products for Mainland China
Finance

Sun Pharma to operate manufacturing plants in Japan

India's drugmaker taps into dermatology market with acquisition of Japan-based Pola Pharma
Pharmaceutical

Sun Pharma opens new cGMP production line in India

The Mumbai-based company has installed a production line in Guwahati to enhance the manufacturing capacity of sterile products

Regulatory filing of tildrakizumab in Europe

Potential of tildrakizumab for patients with moderate-to-severe plaque psoriasis, without burden of frequent injections
Finance

Almirall pays Sun Pharma $50 million upfront in licensing deal for psoriasis treatment in Europe

Phase III clinical trials of tildrakizumab were completed in May, with positive results
Subscribe now